Skip to main content
Premium Trial:

Request an Annual Quote

iCubate, Wondfo Biotech Form Chinese JV to Develop MDx Assays

NEW YORK (GenomeWeb) — iCubate said today that it has formed a joint venture with Wondfo Biotech to commercialize infectious disease molecular diagnostics in China.

The joint venture — called Wondfo-iCubate Biotech — will develop assays using iCubate's amplicon-rescued multiplex PCR (arm-PCR) technology, which the company has said can amplify up to a quarter of a million unique targets in one reaction with high specificity and sensitivity. 

iCubate said that it signed a series of strategic cooperation agreements with Guangzhou-based Wondfo in late 2018 to set the stage for the establishment of Wondfo-iCubate Biotech, and that the joint venture has already secured an industrial and commercial business license to operate within China.

Specific terms of the joint venture deal were not disclosed.

In 2017, Huntsville, Alabama-based iCubate received US Food and Drug Administration clearance for an arm-PCR-based bloodstream infection assay and related diagnostic platform. The company is also currently developing a gram-negative assay that would run on a benchtop, fully integrated cartridge-based molecular diagnostic platform capable of running highly multiplexed assays.

In September, Wondfo Biotech agreed to establish a joint venture with Biocartis to commercialize that company's Idylla molecular diagnostics platform in China.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.